Sofosbuvir, a hepatitis C treatment drug, can adversely interact with tenofovir disoproxil, a HIV treatment drug, according to research led by Bingfang Yan, PhD, professor of biomedical and ...

Gilead Sciences’ Sovaldi, a drug that can cure hepatitis C, was among the top pharmaceutical costs in most states’ Medicaid budgets in 2014, according to a National Public Radio report. Here are four ...

(Reuters Health) - State-run insurance programs for the poor may be putting up illegal barriers that prevent people with hepatitis C from getting a new treatment, a new study suggests. "We had this ...

Mobile telemedicine delivery significantly enhanced HCV treatment initiation for underserved rural populations.

(Reuters) - Idenix Pharmaceuticals Inc's experimental hepatitis C drug was placed on a partial hold by the U.S. health regulator, barely two weeks after Bristol-Myers Squibb Co's hepatitis C treatment ...

The direct-acting antivirals (DAA) for hepatitis C are almost 100 percent effective at curing the infection. Yet only about 1 in 3 people are treated with it in the first year after diagnosis. One ...

Add Yahoo as a preferred source to see more of our stories on Google. A new “meds to beds” program at Barnes-Jewish Hospital dispenses Hepatitis C medication to women before they are discharged after ...

Medicare Part D or MAPD plans should cover hepatitis C medications, but the exact covered drugs depend on the plan. Infused drugs and other treatments are covered by Original Medicare (parts A and B) ...

Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to the Albany Daily Star. 1. The increase in spending will raise the insurance ...

Hepatitis A and hepatitis B can be prevented with vaccines. CDC recommends all eligible gay and bisexual men get vaccinated ...

It’s been almost a year since federal regulators approved a new hepatitis C treatment that costs about $1,000 per pill. But time hasn’t done much to ease concerns of state officials who worry about ...

WASHINGTON (AP) The $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors. The new leading pill for hepatitis C is more ...